Pharmacia Xalcom
Executive Summary
Xalatan (latanoprost) and timolol (Merck's Timoptic and generics) combination product deemed "approvable" June 2 for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta blockers. The application was submitted during the fourth quarter of 1999 and is under priority review. Pharmacia currently markets Xalatan for open-angle glaucoma and ocular hypertension
Xalatan (latanoprost) and timolol (Merck's Timoptic and generics) combination product deemed "approvable" June 2 for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta blockers. The application was submitted during the fourth quarter of 1999 and is under priority review. Pharmacia currently markets Xalatan for open-angle glaucoma and ocular hypertension. |